Bluefin Capital Management, LLC Johnson & Johnson Transaction History

Bluefin Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $204,889 - $227,990	1,270 Added 97.69%	2,570 $420,000
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $571,846 - $632,434	-3,400 Reduced 72.34%	1,300 $230,000
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $830,551 - $943,206	-5,252 Reduced 52.77%	4,700 $833,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $1.93 Million - $2.15 Million	-12,400 Reduced 55.48%	9,952 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $22,448 - $24,946	139 Added 0.63%	22,352 $3.61 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $323,744 - $347,272	-2,030 Reduced 8.37%	22,213 $3.66 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $2.65 Million - $2.95 Million	17,308 Added 249.57%	24,243 $3.98 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $350,178 - $401,948	2,554 Added 58.3%	6,935 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $615,004 - $673,929	4,381 New	4,381 $652,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.